64 Participants Needed
Virginia Commonwealth University logo

E-Cigarette Liquids for Cardiopulmonary Health

PR
Overseen ByPaula Rodriguez Miguelez, PhD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: Virginia Commonwealth University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the user's health. The overall goal of this study is to evaluate the impact of e-cigarettes usage on user's cardiopulmonary health

Research Team

PR

Paula Rodriguez Miguelez, PhD

Principal Investigator

Virginia Commonwealth University

Eligibility Criteria

This trial is for adults over the age of 21 who are either regular e-cigarette users (using them at least three times a week for more than three months) or those who have never used e-cigarettes. It's not specified, but typically people with certain health conditions may be excluded.

Inclusion Criteria

I am 21 or older and do not use e-cigarettes.
I am 21 or older and have been using e-cigarettes regularly for at least 3 months.

Exclusion Criteria

Use of cigarettes for 15 days or more in the past 60 days
I have heart, lung, kidney, liver, metabolic, or brain diseases.
Use of marijuana or any illicit or prescription drugs for non-medical use weekly or more frequently in the past 60 days
See 5 more

Treatment Details

Interventions

  • Tobacco flavored liquid type 1
  • Tobacco flavored liquid type 2
Trial OverviewThe study is testing two types of tobacco-flavored liquids used in cartridge-based electronic cigarettes to see how they affect the heart and lungs of the users. Participants will use these liquids and their cardiopulmonary health will be monitored.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: E-cigarette liquid type 1Experimental Treatment1 Intervention
Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.
Group II: E-cigarettes liquid type 2Active Control1 Intervention
Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.
Group III: No e-cigarettesActive Control1 Intervention
No e-cigarette use

Find a Clinic Near You

Who Is Running the Clinical Trial?

Virginia Commonwealth University

Lead Sponsor

Trials
732
Recruited
22,900,000+